USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
Advances in monoclonal antibody therapeutics
Advances in monoclonal antibody therapeutics
RELEASE DATE
29-Sep-2015
29-Sep-2015
REGION
Global
Global
Research Code: D65E-01-00-00-00
SKU: MX0150-GL-TR_18357
$4,950.00
Special Price $3,712.50 save 25 %
In stock
SKU
MX0150-GL-TR_18357
Description
Monoclonal antibody therapeutics are being used for treatment of a wide array of diseases, specially in therapeutic areas such as oncology, immunology (including autoimmune and inflammatory diseases, as well as, transplant rejection) and neuroscience. The development of these new molecular agents, successfully directed to specific cellular targets, is playing a crucial role in the pharmaceutical industry. This trend shows the strong focus of top biopharmaceutical companies in biologics, including monoclonal antibody therapeutics. This research service discusses the emerging trends in monoclonal antibody therapeutics on a global scale, through a detailed strategic assessment of the industry environment.
Table of Contents
Research Scope
Research Methodology
Key Findings
Technology Snapshot – Multiple Segmentation
Industry Overview – Main Innovations
Industry Overview – Main Innovators
Technology Roadmap Toward Precision Medicine
Therapeutic Areas and Clinical Indications
Molecular Agents and Cell Targets
Developmental Stage Focus
Market Potential
Market Evolution
Venture Capital Investment
Company Stage Investment Focus
Government Funding and Support
Worldwide Landscape
Key Drivers and Restraints
Key Technical and Business Challenges
Industry Assessment – Partnerships and Alliances
Stakeholder Assessment for Partnerships
Partnerships and Alliances Models
Partnerships and Collaborations
Partnerships and Collaborations (continued)
Partnerships and Collaborations (continued)
Patent Analysis
Patent publishing trends
Patent office-wise distribution
R&D Success and Key Performance Indicators
Analytical Hierarchy Process (AHP)
Analytical Hierarchy Process (AHP)
Analytical Hierarchy Process (AHP)
Analytical Hierarchy Process (AHP)
Analytical Hierarchy Process (AHP)
Analytical Hierarchy Process (AHP)
Analytical Hierarchy Process (AHP)
Analytical Hierarchy Process (AHP)
Analytical Hierarchy Process (AHP)
Contacts
Contacts (continued)
Strategic R&D Pipeline – The Road Ahead
R&D Pipeline Assessment
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
R&D Pipeline Assessment (continued)
Product Line Assessment
Product Line Assessment (continued)
Product Line Assessment (continued)
Product Line Assessment (continued)
Product Line Assessment (continued)
Product Line Assessment (continued)
Product Line Assessment (continued)
Product Line Assessment (continued)
Product Line Assessment (continued)
Product Line Assessment (continued)
Abbreviations
Legal Disclaimer
The Frost & Sullivan Story
Value Proposition: Future of Your Company & Career
Global Perspective
Industry Convergence
360º Research Perspective
Implementation Excellence
Our Blue Ocean Strategy
Popular Topics
electric vehicle market analysis
biometric authentication market
Monoclonal antibody therapeutics are being used for treatment of a wide array of diseases, specially in therapeutic areas such as oncology, immunology (including autoimmune and inflammatory diseases, as well as, transplant rejection) and neuroscience. The development of these new molecular agents, successfully directed to specific cellular targets, is playing a crucial role in the pharmaceutical industry. This trend shows the strong focus of top biopharmaceutical companies in biologics, including monoclonal antibody therapeutics. This research service discusses the emerging trends in monoclonal antibody therapeutics on a global scale, through a detailed strategic assessment of the industry environment.
| No Index | No |
|---|---|
| Podcast | No |
| Author | Cecilia Van Cauwenberghe |
| Industries | Healthcare |
| WIP Number | D65E-01-00-00-00 |
| Is Prebook | No |